HIV News and Research

RSS

New study describes molecular basis of NeuroAIDS

Using multi-disciplinary analysis that included cognitive, neurophysiologic, virologic, and molecular techniques, the team found both a low-level viral infection in the brain and immune cells that had infiltrated the brain in order to protect against the virus.

3 May 2006

Outcome of patients with hepatitis B and HIV infections referred for liver transplantation

A new study on HIV patients who also had Hepatitis B virus (HBV) found that better outcomes are possible if they are referred early for transplant and treated with a combination of drugs for HBV. It is essential to monitor the HBV status of these patients, however, in order to control the emergence of drug-resistant HBV infection.

3 May 2006

Good and bad sides of the Internet as it relates to children

Between 75 and 90 percent of teenagers in the United States use the Internet to email, instant message (IM), visit chat rooms and explore other sites on the World Wide Web.

3 May 2006

Study investigates early biology of HIV infection

In July 2005, the race to find a vaccine that would stem the worldwide rate of 13,000 new cases of HIV infection each day moved from competition among research institutions to a strategy of cooperation.

2 May 2006

'Resonance' may be the reason for virologic failure in STI drug therapy

Researchers have been puzzled over why HIV-positive patients who have periodic, built in interruptions in their drug therapy reach a point where the therapy no longer reduces their viral loads, even in the absence of any evidence of acquired drug resistance.

25 Apr 2006

Time for Russians to get serious about HIV/AIDS

Rapidly growing numbers of HIV-infections in Russia has prompted President Vladimir Putin to order officials to do more to inform Russians about the dangers of HIV/AIDS.

24 Apr 2006

Vaginal gel zaps AIDS virus - gives women control

According to the researchers if current trials are satisfactory, a safe and effective gel which protects women from the AIDS virus may be available by 2010.

24 Apr 2006

Novel approach used to neutralize anthrax toxin

Researchers from Rensselaer Polytechnic Institute and the University of Toronto have designed a nanoscale assembly of molecules that successfully counteracts and inhibits anthrax toxin in animal and laboratory experiments.

23 Apr 2006

Treating populations infected with both HIV and latent TB could speed the emergence of drug-resistant TB

In 2005, 46 regional Ministers of Health in Africa declared that a dramatic rise in tuberculosis (TB) cases was cause for emergency.

19 Apr 2006

Primagen awarded U.S. patent for using mitochondrial DNA quantification as biomarker

Primagen Holding BV has announced that the U.S. Patent and Trademark Office has granted a patent for its Mitox mitochondrial DNA quantification technology as biomarkers for efficacy and adverse events of treatment.

19 Apr 2006

BET, Kaiser Family Foundation and Scenarios USA team up on youth HIV scriptwriting contest

BET and the Kaiser Family Foundation, through Rap-It-Up, the award winning HIV/AIDS public education initiative, have teamed up with Scenarios USA to create the 2006 Scenarios USA/Rap It Up Story and Scriptwriting Contest.

17 Apr 2006

Europe slow to implement infant pneumococcal vaccine programmes

Up to 90 per cent of cases of invasive pneumococcal diseases (IPD) - which includes serious infections like meningitis - occur in otherwise healthy young children, according to a study published in the April issue of IJCP, the International Journal of Clinical Practice.

13 Apr 2006

Researchers identify critical human cell surface molecule involved in infection by Kaposi's sarcoma herpesvirus

Researchers at the National Institute of Allergy and Infectious Disease (NIAID) have identified a critical human cell surface molecule involved in infection by Kaposi's sarcoma herpesvirus (KSHV), the virus that causes Kaposi's sarcoma and certain forms of lymphoma.

11 Apr 2006

Researchers unravel structure of important new drug target that could potentially treat SARS-infected patients

Mesecar said that the knowledge gained from this new atomic structure - the first-ever reported on this class of proteases - has the potential to go beyond the treatment of patients infected with the coronavirus that causes SARS.

11 Apr 2006

Surprising discovery about the inner workings of vesicular stomatitis virus

Biochemists at Wake Forest University School of Medicine have made a surprising discovery about the inner workings of a powerful virus - a discovery that they hope could one day lead to better vaccines or anti-virus medications.

11 Apr 2006

WHO report says rich must stop poaching medical staff from poor

A critical shortage of doctors and nurses is causing unnecessary disease and death across much of the developing world as rich nations poach health-care workers.

10 Apr 2006

Cognitive impairment in people with AIDS exists in two forms

The researchers say their findings indicate there probably are two separate mechanisms that can cause cognitive impairment in people with AIDS.

10 Apr 2006

Ceftriaxone may help fight dementia in HIV patients

An antibiotic commonly used to treat a variety of serious infections may also help prevent dementia in HIV patients, according to a test-tube study of human brain cells by Johns Hopkins University School of Medicine neurologist Jeffrey Rumbaugh, M.D., Ph.D.

7 Apr 2006

Bush's AIDS prevention policy doing more harm than good

According to a new report issued by the U.S. Government Accountability Office (GAO), the U.S. approach to AIDS prevention is essentially unworkable.

5 Apr 2006

Multi-site vaccinations could protect against all four dengue viruses

An innovative new study explains, for the first time, the failure of previous attempts to vaccinate against the four known Dengue viruses, and it suggests a very simple solution - injecting the four vaccines simultaneously at different locations on the body.

4 Apr 2006